3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年7月31日) | 当連結会計年度 (2026年7月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 9,157 | 7,791 |
受取手形及び売掛金 | 5,038 | 3,916 |
電子記録債権 | 247 | 74 |
商品及び製品 | 6,311 | 7,533 |
仕掛品 | 675 | 820 |
原材料及び貯蔵品 | 864 | 790 |
その他 | 1,576 | 2,102 |
貸倒引当金 | △0 | △0 |
流動資産合計 | 23,870 | 23,029 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 2,082 | 2,068 |
機械装置及び運搬具(純額) | 708 | 619 |
工具、器具及び備品(純額) | 518 | 441 |
土地 | 1,194 | 1,196 |
リース資産(純額) | 27 | 20 |
建設仮勘定 | 164 | 3,671 |
有形固定資産合計 | 4,696 | 8,018 |
無形固定資産 | | |
のれん | 71 | 37 |
その他 | 49 | 48 |
無形固定資産合計 | 120 | 85 |
投資その他の資産 | | |
投資有価証券 | 2,450 | 2,670 |
繰延税金資産 | 515 | 630 |
その他 | 996 | 681 |
投資その他の資産合計 | 3,961 | 3,982 |
固定資産合計 | 8,778 | 12,085 |
資産合計 | 32,649 | 35,115 |
| | (単位:百万円) |
| 前連結会計年度 (2025年7月31日) | 当連結会計年度 (2026年7月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 1,923 | 1,413 |
短期借入金 | 11,400 | 13,400 |
1年内返済予定の長期借入金 | 560 | 560 |
未払金 | 3,520 | 1,292 |
未払法人税等 | 1,494 | 418 |
賞与引当金 | 72 | 74 |
その他 | 1,034 | 1,107 |
流動負債合計 | 20,005 | 18,265 |
固定負債 | | |
長期借入金 | 671 | 3,211 |
退職給付に係る負債 | 378 | 374 |
その他 | 45 | 96 |
固定負債合計 | 1,096 | 3,682 |
負債合計 | 21,101 | 21,948 |
純資産の部 | | |
株主資本 | | |
資本金 | 2,043 | 2,043 |
資本剰余金 | 1,814 | 1,814 |
利益剰余金 | 7,691 | 8,969 |
自己株式 | △195 | △26 |
株主資本合計 | 11,353 | 12,800 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 193 | 365 |
その他の包括利益累計額合計 | 193 | 365 |
純資産合計 | 11,547 | 13,166 |
負債純資産合計 | 32,649 | 35,115 |
E0248429290株式会社ファーマフーズ通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-08-012026-07-31FY2026-07-312024-08-012025-07-312025-07-311falsefalsefalse292902025-08-012026-07-31jppfs_cor:CapitalStockMember292902025-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember292902025-07-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember292902025-07-31jppfs_cor:ShareholdersEquityMember292902025-07-31jppfs_cor:TreasuryStockMember292902025-07-31jppfs_cor:RetainedEarningsMember292902025-07-31jppfs_cor:CapitalSurplusMember292902025-07-31jppfs_cor:CapitalStockMember292902026-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember292902026-07-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember292902026-07-31jppfs_cor:ShareholdersEquityMember292902026-07-31jppfs_cor:TreasuryStockMember292902026-07-31jppfs_cor:RetainedEarningsMember292902026-07-31jppfs_cor:CapitalSurplusMember292902026-07-31jppfs_cor:CapitalStockMember292902024-07-31292902024-08-012025-07-31292902026-09-11292902026-07-31292902025-08-012026-07-31292902025-07-31292902024-07-31jppfs_cor:TreasuryStockMember292902024-08-012025-07-31jppfs_cor:TreasuryStockMember292902024-08-012025-07-31jpcrp_cor:ReportableSegmentsMember292902024-08-012025-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember292902026-07-31jpcrp_cor:ReportableSegmentsMember292902025-08-012026-07-31jpcrp_cor:ReportableSegmentsMember292902025-08-012026-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember292902025-07-31jpcrp_cor:ReportableSegmentsMember292902024-08-012025-07-31tse-acedjpfr-29290:BtoBReportableSegmentsMember292902024-08-012025-07-31tse-acedjpfr-29290:BtoCReportableSegmentsMember292902024-08-012025-07-31tse-acedjpfr-29290:BioMedicalReportableSegmentsMember292902024-08-012025-07-31jpcrp_cor:ReconcilingItemsMember292902026-07-31tse-acedjpfr-29290:BtoBReportableSegmentsMember292902026-07-31tse-acedjpfr-29290:BtoCReportableSegmentsMember292902026-07-31tse-acedjpfr-29290:BioMedicalReportableSegmentsMember292902026-07-31jpcrp_cor:ReconcilingItemsMember292902025-08-012026-07-31tse-acedjpfr-29290:BtoBReportableSegmentsMember292902025-08-012026-07-31tse-acedjpfr-29290:BtoCReportableSegmentsMember292902025-08-012026-07-31tse-acedjpfr-29290:BioMedicalReportableSegmentsMember292902025-08-012026-07-31jpcrp_cor:ReconcilingItemsMember292902025-07-31tse-acedjpfr-29290:BtoBReportableSegmentsMember292902025-07-31tse-acedjpfr-29290:BtoCReportableSegmentsMember292902025-07-31tse-acedjpfr-29290:BioMedicalReportableSegmentsMember292902025-07-31jpcrp_cor:ReconcilingItemsMember292902024-08-012025-07-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember292902025-08-012026-07-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember292902025-08-012026-07-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember292902025-08-012026-07-31jppfs_cor:ShareholdersEquityMember292902025-08-012026-07-31jppfs_cor:TreasuryStockMember292902025-08-012026-07-31jppfs_cor:RetainedEarningsMember292902025-08-012026-07-31jppfs_cor:CapitalSurplusMember292902024-07-31jppfs_cor:CapitalStockMember292902024-07-31jppfs_cor:CapitalSurplusMember292902024-07-31jppfs_cor:RetainedEarningsMember292902024-07-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember292902024-07-31jppfs_cor:ShareholdersEquityMember292902024-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember292902024-08-012025-07-31jppfs_cor:CapitalStockMember292902024-08-012025-07-31jppfs_cor:CapitalSurplusMember292902024-08-012025-07-31jppfs_cor:RetainedEarningsMember292902024-08-012025-07-31jppfs_cor:ShareholdersEquityMember292902024-08-012025-07-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember292902024-08-012025-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember292902025-08-012026-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMemberiso4217:JPYxbrli:pure